Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 499 participants.

Also called NCT02548455

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 499 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02548455
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02548455. Allocation not applicable; no masking; primary purpose treatment. Start 2015-10-27 (actual); primary completion 2016-08-19 (actual). Results posted on 2018-05-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study
Condition
Heart Failure
Intervention (Device)
Quartet 1457Q LV Lead
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct02548455
Content hash
749bed01e3c5227b7abb20c7492d14a792ba4e3ba3a4fced6c3c709b34ecca35